Waldenstrom macroglobulinemia: A review of therapy

被引：13
|
作者：
Gertz, MA [1 ]
机构：
[1] Mayo Clin, Div Hematol & Internal Med, Rochester, MN 55905 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2005年 / 79卷 / 02期
关键词：
hyperviscosity syndrome; lymphoplasmacytic lymphoma; monoclonal antibody therapy; monoclonal gammopathy; Waldenstrom macroglobulinemia;
D O I：
10.1002/ajh.20363
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Waldenstrom macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenstrom macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码：147 / 157
页数：11
相关论文
共 50 条
  • [31] microRNA expression in the biology, prognosis, and therapy of Waldenstrom macroglobulinemia
    Roccaro, Aldo M.
    Sacco, Antonio
    Chen, Changzhong
    Runnels, Judith
    Leleu, Xavier
    Azab, Feda
    Azab, Abdel Kareem
    Jia, Xiaoying
    Ngo, Hai T.
    Melhem, Molly R.
    Burwick, Nicholas
    Varticovski, Lyuba
    Novina, Carl D.
    Rollins, Barrett J.
    Anderson, Kenneth C.
    Ghobrial, Irene M.
    [J]. BLOOD, 2009, 113 (18) : 4391 - 4402
  • [32] CHOP plus Rituximab therapy in Waldenstrom's macroglobulinemia
    Treon, SP
    Hunter, Z
    Branagan, AR
    [J]. CLINICAL LYMPHOMA, 2005, 5 (04): : 273 - 277
  • [33] Carfilzomib as salvage therapy in Waldenstrom macroglobulinemia: a case series
    Vesole, David H.
    Richter, Joshua
    Biran, Noa
    McBride, Laura
    Anand, Palka
    Huang, Mei
    Kumeli, Anita-Zahlten
    Klippel, Zandra
    Iskander, Karim
    Siegel, David S.
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 259 - 261
  • [34] Waldenstrom Macroglobulinemia: A Review of the Entity and Its Differential Diagnosis
    Shaheen, Saad P.
    Talwalkar, Sameer S.
    Lin, Pei
    Medeiros, L. Jeffrey
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2012, 19 (01) : 11 - 27
  • [35] Bruton tyrosine kinase inhibitors for Waldenstrom macroglobulinemia: A review
    Moore, Donald C.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) : 1993 - 1999
  • [36] Waldenstrom's macroglobulinemia
    Dimopoulos, M. A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S25 - S25
  • [37] IGG WALDENSTROM MACROGLOBULINEMIA
    VELASCO, FP
    [J]. MEDICINA CLINICA, 1992, 99 (20): : 798 - 798
  • [38] Expression in Waldenstrom macroglobulinemia
    Owen, R. G.
    Fan, I.
    O'Connor, S. J. M.
    Jack, A. S.
    Rawstron, A. C.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 223 - 223
  • [39] The epidemiology of Waldenstrom macroglobulinemia
    McMaster, Mary L.
    [J]. SEMINARS IN HEMATOLOGY, 2023, 60 (02) : 65 - 72
  • [40] THE HISTOPATHOLOGY OF THE MACROGLOBULINEMIA OF WALDENSTROM
    DUTCHER, TF
    FAHEY, JL
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1959, 22 (05) : 887 - 917
12345